China Health Management Stock EBITDA
| CNHC Stock | USD 0 0 34.43% |
China Health Management fundamentals help investors to digest information that contributes to China Health's financial success or failures. It also enables traders to predict the movement of China Pink Sheet. The fundamental analysis module provides a way to measure China Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to China Health pink sheet.
China |
China Health Management Company EBITDA Analysis
China Health's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, China Health Management reported earnings before interest,tax, depreciation and amortization of 0.0. This is 100.0% lower than that of the Technology Hardware, Storage & Peripherals sector and about the same as Information Technology (which currently averages 0.0) industry. The ebitda for all United States stocks is 100.0% higher than that of the company.
China EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses China Health's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of China Health could also be used in its relative valuation, which is a method of valuing China Health by comparing valuation metrics of similar companies.China Health is currently under evaluation in ebitda category among its peers.
China Fundamentals
| Profit Margin | (0.24) % | |||
| Operating Margin | (0.21) % | |||
| Current Valuation | 17.53 M | |||
| Shares Outstanding | 81.15 M | |||
| Price To Earning | (1.80) X | |||
| Price To Sales | 3.18 X | |||
| Revenue | 542.38 K | |||
| Gross Profit | 108.47 K | |||
| Net Income | (129.28 K) | |||
| Current Ratio | 1.09 X | |||
| Book Value Per Share | 0 X | |||
| Earnings Per Share | (0) X | |||
| Number Of Employees | 13 | |||
| Beta | 1.28 | |||
| Market Capitalization | 929.12 K | |||
| Total Asset | 5.2 M | |||
| Retained Earnings | (34.26 M) | |||
| Working Capital | 5.16 M | |||
| Current Asset | 9.37 M | |||
| Current Liabilities | 4.21 M | |||
| Z Score | -8.4 | |||
| Net Asset | 5.2 M |
About China Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze China Health Management's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of China Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of China Health Management based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in China Pink Sheet
China Health financial ratios help investors to determine whether China Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in China with respect to the benefits of owning China Health security.